Latest Chinese Drug Coverage Comes With Steep Price Cuts, Caveats

But Bigger Volumes Await

 
• By Dexter Jie Yan
  
Chines biotechs have won wider market access with reimbursement coverage in China.
reimbursement coverage gives Chinese biotechs wider market access - at a cost • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia